These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21726796)

  • 1. Advanced topics in evidence-based urologic oncology: economic analysis.
    Vogel B; Gilbert SM; Boylston Herndon J; Dahm P
    Urol Oncol; 2011; 29(4):454-61. PubMed ID: 21726796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to a new series: advanced topics in evidence-based urologic oncology.
    Canfield SE; Dahm P
    Urol Oncol; 2011; 29(4):446. PubMed ID: 21726794
    [No Abstract]   [Full Text] [Related]  

  • 3. Using economic evidence in clinical practice.
    Stone PW
    J Med Pract Manage; 2002; 17(5):272-7. PubMed ID: 12024866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical-economic analysis: a necessary complement to "evidence based medicine"].
    Wasserfallen JB
    Rev Med Suisse Romande; 2001 Apr; 121(4):265-8. PubMed ID: 11400397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced topics in evidence-based urological oncology: using results of a subgroup analysis.
    Scales CD; Canfield SE
    Urol Oncol; 2011; 29(4):462-6. PubMed ID: 21726797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
    Johansson B; Ridderheim M; Glimelius B
    Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of proton radiation therapy in the treatment of breast cancer.
    Lundkvist J; Ekman M; Ericsson SR; Isacsson U; Jönsson B; Glimelius B
    Radiother Oncol; 2005 May; 75(2):179-85. PubMed ID: 15885828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced topics in evidence-based urologic oncology: surrogate endpoints.
    Lavallée LT; Montori VM; Canfield SE; Breau RH
    Urol Oncol; 2011; 29(4):447-53. PubMed ID: 21726795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology evolution: is it survival of the fittest?
    Zietman A; Goitein M; Tepper JE
    J Clin Oncol; 2010 Sep; 28(27):4275-9. PubMed ID: 20697074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness studies in radiation therapy.
    Sher DJ
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in cost effectiveness analyses in orthopaedic surgery.
    Brauer CA; Neumann PJ; Rosen AB
    Clin Orthop Relat Res; 2007 Apr; 457():42-8. PubMed ID: 17242614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expensive care - a rationale for economic evaluations in intensive care.
    Higgins AM; Pettila V; Bellomo R; Harris AH; Nichol AD; Morrison SS
    Crit Care Resusc; 2010 Mar; 12(1):62-6. PubMed ID: 20196716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The practice of urologic oncology: some economic realties.
    Loughlin KR
    Urol Oncol; 2012; 30(4 Suppl):S5-9. PubMed ID: 22795080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence based clinical practice: a primer for urologists.
    Scales CD; Preminger GM; Keitz SA; Dahm P
    J Urol; 2007 Sep; 178(3 Pt 1):775-82. PubMed ID: 17631350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic approach to health care.
    Homik JE; Suarez-Almazor M
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):203-18. PubMed ID: 15121040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.